As we enter a new era of value and outcomes-based healthcare, exercising “systems thinking” – accounting for political, economic, social and technological factors – will be critical to our collective success in improving population health. Now more than ever, industry players must team up with other healthcare stakeholders if they want to improve system performance and optimize patient outcomes. Biopharma companies who do will be amply rewarded for their innovation and contribution to healthcare system value and outcomes.